DK185685D0 - 1,4-dihydro-4-oxonaphthyridinderivater og salte deraf, fremgangsmaade til fremstilling heraf og antibakterielle midler indeholdende saadanne forbindelser - Google Patents

1,4-dihydro-4-oxonaphthyridinderivater og salte deraf, fremgangsmaade til fremstilling heraf og antibakterielle midler indeholdende saadanne forbindelser

Info

Publication number
DK185685D0
DK185685D0 DK185685A DK185685A DK185685D0 DK 185685 D0 DK185685 D0 DK 185685D0 DK 185685 A DK185685 A DK 185685A DK 185685 A DK185685 A DK 185685A DK 185685 D0 DK185685 D0 DK 185685D0
Authority
DK
Denmark
Prior art keywords
dihydro
procedures
salts
preparing
compounds
Prior art date
Application number
DK185685A
Other languages
English (en)
Other versions
DK165877C (da
DK185685A (da
DK165877B (da
Inventor
Hirokazu Narita
Yoshinori Konishi
Jun Nitta
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuji
Shinzaburo Minami
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK185685(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of DK185685D0 publication Critical patent/DK185685D0/da
Publication of DK185685A publication Critical patent/DK185685A/da
Publication of DK165877B publication Critical patent/DK165877B/da
Application granted granted Critical
Publication of DK165877C publication Critical patent/DK165877C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK185685A 1984-04-26 1985-04-25 1,4-dihydro-6-fluor-4-oxo-1,8-naphthyridin-3-carboxylsyrederivater og salte deraf, antibakterielle praeparater indeholdende saadanne forbindelser DK165877C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8496384 1984-04-26
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (4)

Publication Number Publication Date
DK185685D0 true DK185685D0 (da) 1985-04-25
DK185685A DK185685A (da) 1985-10-27
DK165877B DK165877B (da) 1993-02-01
DK165877C DK165877C (da) 1993-06-21

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
DK185685A DK165877C (da) 1984-04-26 1985-04-25 1,4-dihydro-6-fluor-4-oxo-1,8-naphthyridin-3-carboxylsyrederivater og salte deraf, antibakterielle praeparater indeholdende saadanne forbindelser

Country Status (30)

Country Link
JP (1) JPS60228479A (da)
KR (1) KR870001693B1 (da)
AR (1) AR241911A1 (da)
AT (2) AT389698B (da)
AU (2) AU565087B2 (da)
BE (1) BE902279A (da)
CH (1) CH673458A5 (da)
CS (1) CS250684B2 (da)
DD (1) DD238795A5 (da)
DE (2) DE3514076A1 (da)
DK (1) DK165877C (da)
EG (1) EG17339A (da)
ES (2) ES8700256A1 (da)
FI (1) FI80453C (da)
FR (2) FR2563521B1 (da)
GB (2) GB2158825B (da)
HU (2) HU197571B (da)
ID (1) ID21142A (da)
IL (1) IL75021A (da)
IT (1) IT1209953B (da)
LU (1) LU85871A1 (da)
NL (2) NL187314C (da)
NO (1) NO162238C (da)
NZ (1) NZ211895A (da)
PH (3) PH22801A (da)
PL (1) PL147392B1 (da)
PT (1) PT80349B (da)
RO (2) RO95509B (da)
SE (2) SE463102B (da)
ZA (1) ZA853102B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
AU1161492A (en) * 1991-01-14 1992-08-17 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
WO1997040036A1 (fr) 1996-04-19 1997-10-30 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
KR20000052892A (ko) * 1996-10-30 2000-08-25 빌프리더 하이더 나프티리딘 화합물의 제조 방법 및 신규 중간 생성물
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
KR100768034B1 (ko) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
EP1313708A1 (en) * 2000-08-29 2003-05-28 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
RO91871B (ro) 1987-07-31
ATA267888A (de) 1989-09-15
GB8510297D0 (en) 1985-05-30
CH673458A5 (da) 1990-03-15
PH25046A (en) 1991-01-28
FR2563521A1 (fr) 1985-10-31
CS250684B2 (en) 1987-05-14
NO162238C (no) 1989-12-06
ES542584A0 (es) 1986-09-16
GB2158825A (en) 1985-11-20
IT1209953B (it) 1989-08-30
AU612993B2 (en) 1991-07-25
PT80349B (pt) 1987-09-30
IT8548002A0 (it) 1985-04-26
DE3514076A1 (de) 1985-10-31
SE463102B (sv) 1990-10-08
FR2614620A1 (fr) 1988-11-04
FI851637A0 (fi) 1985-04-25
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
PL253108A1 (en) 1985-12-17
NZ211895A (en) 1988-07-28
IL75021A0 (en) 1985-08-30
HUT38634A (en) 1986-06-30
AT389698B (de) 1990-01-10
KR870001693B1 (ko) 1987-09-24
SE8804586L (sv) 1988-12-20
KR850007596A (ko) 1985-12-07
DK165877C (da) 1993-06-21
FI80453C (fi) 1990-06-11
IL75021A (en) 1994-01-25
SE8502017D0 (sv) 1985-04-25
RO91871A (ro) 1987-07-30
AU8180487A (en) 1988-03-24
FR2614620B1 (fr) 1990-03-09
GB2191776B (en) 1990-03-28
BE902279A (fr) 1985-10-25
GB8716897D0 (en) 1987-08-26
NL187314C (nl) 1991-08-16
DE3514076C2 (da) 1989-03-30
DK185685A (da) 1985-10-27
SE8502017L (sv) 1985-10-27
AT390258B (de) 1990-04-10
FI80453B (fi) 1990-02-28
SE8804586D0 (sv) 1988-12-20
PH25228A (en) 1991-03-27
RO95509A (ro) 1988-09-30
ID21142A (id) 1999-04-29
AU565087B2 (en) 1987-09-03
RO95509B (ro) 1988-10-01
DD238795A5 (de) 1986-09-03
PL147392B1 (en) 1989-05-31
AR241911A1 (es) 1993-01-29
NO851643L (no) 1985-10-28
PT80349A (en) 1985-05-01
DK165877B (da) 1993-02-01
PH22801A (en) 1988-12-12
FI851637L (fi) 1985-10-27
JPS6320828B2 (da) 1988-04-30
SE501412C2 (sv) 1995-02-13
HU197571B (en) 1989-04-28
ES8700256A1 (es) 1986-09-16
EG17339A (en) 1989-06-30
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
ZA853102B (en) 1986-12-30
LU85871A1 (en) 1985-12-16
GB2158825B (en) 1989-01-25
ES551538A0 (es) 1987-07-01
JPS60228479A (ja) 1985-11-13
FR2563521B1 (fr) 1989-02-03
AU4165085A (en) 1985-10-31
HU194226B (en) 1988-01-28
NL8501172A (nl) 1985-11-18
ATA122485A (de) 1989-06-15
DE3546658C2 (da) 1992-04-02

Similar Documents

Publication Publication Date Title
DK185685A (da) 1,4-dihydro-4-oxonaphthyridinderivater og salte deraf, fremgangsmaade til fremstilling heraf og antibakterielle midler indeholdende saadanne forbindelser
DK467388A (da) Quinolon- og naphthyridinderivater, antibakterielle midler indeholdende disse og fremgangsmaader til fremstilling deraf
DK577084D0 (da) 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf
DK381485A (da) 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf
DK316784D0 (da) 1,2,4-triazol-3-on-derivater og fremgangsmaade til fremstilling deraf
DK590586A (da) 5-amino- og 5-hydroxy-6,8-difluorquinoloner og salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
DK468284A (da) 1,2,4-triazolonderivater og fremgangsmaade til fremstilling deraf
DK572183D0 (da) 7-carboxymethoxyphenylacetamido-3-cephemderivater,fremgangsmaade til fremstilling deraf og antibakterielle praeparater indeholdende forbindelserne
DK162221C (da) Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
DK162886C (da) 1,4-dihydropyridin-derivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende forbindelserne
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
DK491385A (da) 1,2,4-triazolocarbamater og deres syreadditionssalte, fremgangsmaader til deres fremstilling og laegemidler indeholdende saadanne forbindelser
EP0159708A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for produing the same
ES538157A0 (es) Procedimiento para preparar derivados de 1,4-dihidropiridina
DK52885A (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DK522683D0 (da) 2-heterocyclyl-lavalkyl-2-penemforbindelser og salte og isomere deraf samt fremgangsmade til fremstilling deraf
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
DK490385A (da) 6-phenethylaminoalkyl-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende saadanne forbindelser
DK222284D0 (da) 2-heterocyclyllavalkyl-2-penemforbindelser og salte deraf samt fremgangsmaade til fremstilling deraf
DK483185D0 (da) 5-(1-cyano-1-alkyl-n-methyl-n-methoxy-phenetyl)-alkylamino-2,2,8-trimethyl-4h-dioxino-(4,5-c)-pyridinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne forbindelser
AR241137A1 (es) "procedimiento para preparar beta-metilen-2 o 3-tiofenetanamina".
MX157611A (es) Procedimiento para preparar derivados de-3-azabiciclo(3.3.1)nonano
DK402885A (da) 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne forbindelser
DK164670C (da) Pyrrolooe3,2,1-hiaaindol-derivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende saadanne forbindelser
DK512185D0 (da) 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser

Legal Events

Date Code Title Description
PUP Patent expired